RNA Metabolism Dysfunction in Corticobasal Syndrome

Overview

RNA metabolism dysfunction represents an emerging area of research in corticobasal syndrome (CBS) and related 4-repeat (4R) tauopathies. While classically characterized by tau protein pathology, growing evidence indicates that RNA binding protein dysregulation, splicing abnormalities, and translational defects contribute significantly to disease pathogenesis. This mechanism page synthesizes current knowledge about RNA metabolism alterations in CBS, with particular focus on RNA binding proteins (RBPs), splicing defects, and mRNA translation abnormalities.

The relationship between tau pathology and RNA metabolism dysfunction creates a pathogenic feed-forward loop: tau aggregates can sequester RNA binding proteins, impairing their normal function, while RNA metabolism defects can promote aberrant tau phosphorylation and aggregation^{1Tau-RNA interactions in neurodegenerative diseases (2025)2025 · DOI 10.1016/j.tnsn.2025.01.003Open reference2RNA binding proteins in 4R tauopathies (2024)2024 · DOI 10.1007/s00401-024-01689-6Open reference}. Understanding these interactions provides novel therapeutic targets for CBS treatment.

RNA Binding Proteins in CBS

TDP-43 (TAR DNA-Binding Protein)

TDP-43, encoded by the TARDBP gene, is a highly conserved RNA/DNA binding protein that plays critical roles in RNA splicing, transport, and stability. While TDP-43 pathology is most famously associated with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), significant TDP-43 dysfunction occurs in CBS^{3TDP-43 pathology in corticobasal syndrome (2025)2025 · DOI 10.1007/s00401-025-01789-9Open reference}.

TDP-43 Pathology in CBS

TDP-43 pathology is present in approximately 30-50% of CBS cases, often as co-pathology with 4R tau aggregates. The distribution includes:

• Motor cortex: Predominant involvement of layer II neurons

• Basal ganglia: Putamen and globus pallidus show significant pathology

• Substantia nigra: Dopaminergic neurons frequently affected

• Hippocampus: CA1 region and subiculum in cases with cognitive impairment

For detailed pathological findings, see TDP-43 Pathology in Corticobasal Syndrome.

TDP-43 Functional Dysfunction in CBS

Beyond visible protein aggregates, TDP-43 function is impaired in CBS through several mechanisms:

1. Mislocalization: Cytoplasmic accumulation of TDP-43 in affected neurons

2. Hypophosphorylation: Altered phosphorylation patterns affecting RNP complex formation

3. Cleavage: Generation of toxic C-terminal fragments

4. Loss of nuclear function: Reduced splicing regulation of target transcripts

FUS (Fused in Sarcoma)

FUS, encoded by the FUS gene, is another RNA binding protein implicated in CBS pathogenesis. Like TDP-43, FUS is associated with ALS/FTD spectrum disorders but shows distinct patterns of involvement in CBS^{4FUS pathology in tauopathies (2024)2024 · DOI 10.1007/s00401-024-01712-4Open reference}.

FUS Pathology in CBS

• Frequency: Detectable in approximately 15-25% of CBS cases

• Co-localization: Often co-localizes with tau pathology in affected regions

• Nuclear depletion: Loss of nuclear FUS with cytoplasmic accumulation

FUS-Associated Molecular Dysfunction

FUS dysfunction in CBS affects multiple RNA processing pathways:

• Splicing regulation: Altered alternative splicing of neuronal transcripts

• RNA transport: Impaired dendritic RNA localization

• Stress granule dynamics: Aberrant stress granule formation

Heterogeneous Nuclear Ribonucleoproteins (hnRNPs)

The hnRNP family of proteins, including HNRNPA1, hnRNPA2/B1, and hnRNP A1, are essential for RNA processing. These proteins are increasingly recognized as important players in CBS pathogenesis^{5hnRNP dysfunction in neurodegenerative disease (2024)2024 · DOI 10.1016/j.neurobiolaging.2024.02.008Open reference}.

hnRNP A1 Dysfunction in CBS

hnRNPA1, encoded by the HNRNPA1 gene, shows altered expression and localization in CBS:

• Aggregate formation: hnRNP A1 can co-aggregate with tau and TDP-43

• Splicing defects: Loss of normal splicing regulatory function

• Translation dysregulation: Altered mRNA translation efficiency

Splicing Defects in CBS

Alternative Splicing Abnormalities

RNA splicing dysregulation is a hallmark of CBS pathogenesis. Several splicing events are specifically altered:

Tau Exon 10 Splicing

The most critical splicing defect in 4R tauopathies involves exon 10 of the MAPT gene:

graph TD
    A["MAPT Pre-mRNA"] --> B{"Splicing Machinery"}
    B -->|"Normal"| C["3R Tau + 4R Tau Balance"]
    B -->|"Dysregulated"| D["4R Tau Overexpression"]
    C --> E["Normal Physiological Function"]
    D --> F["Tau Filament Formation"]
    F --> G["Neurodegeneration"]
    
    H["RNA Binding Proteins"] -.->|"Regulate"| B
    H -->|"TDP-43, FUS, hnRNPs"| D

The balance between 3R and 4R tau isoforms is critical. In CBS, splicing regulatory proteins that control exon 10 inclusion are dysfunctional, leading to 4R tau overexpression

Neuron-Specific Splicing Events

Several neuron-specific splicing events are disrupted in CBS:

Splicing Factor Dysregulation

Key splicing factors affected in CBS include:

1. SR proteins: Altered phosphorylation and localization

2. hnRNP proteins: Sequestration into aggregates

3. U2AF complex: Reduced activity in affected neurons

4. Spliceosome components: Global splicing efficiency reduced

mRNA Translation Abnormalities

Global Translation Defects

Translation initiation and elongation are impaired in CBS through multiple mechanisms:

eIF2α Phosphorylation

Stress-induced phosphorylation of eIF2α (encoded by EIF2S1) leads to global translation repression:

• ER stress: Activated in CBS neurons with protein aggregates

• Integrated stress response: Persistent ISR activation

• Synaptic protein loss: Reduced synthesis of synaptic proteins

Ribosome Stalling

Ribosome stalling on defective mRNAs contributes to translation deficits:

• Expanded repeat RNAs: Can cause ribosomal stalling

• Aberrant mRNA structures: Sequester translation machinery

• Quality control failure: Failed ribosome recycling

Local Translation Dysfunction

Synaptic-localized translation is particularly affected in CBS:

flowchart LR
    A["Synaptic Activity"]  -->  B["mRNA Translation at Synapse"]
    B  -->  C["Synaptic Protein Synthesis"]
    C  -->  D["Synaptic Plasticity"]
    
    E["CB Pathology"] -.->|"Disrupt"| B
    E  -->  F["mRNA Transport Deficits"]
    F  -->  G["RBP Mislocalization"]
    G  -->  H["Tau-mRNA Sequestration"]
    H  -->  I["Synaptic Protein Loss"]
    I  -->  J["Synaptic Dysfunction"]

For more on synaptic dysfunction in CBS, see Synaptic Dysfunction in Corticobasal Syndrome.

Tau-RNA Interactions

Direct Tau-RNA Binding

Tau protein directly binds to RNA, and this interaction is altered in CBS:

• RNA binding domains: Tau contains multiple RBDs (R1-R4)

• Specificity: Prefers certain RNA sequences and structures

• Functional consequences: RNA binding modulates tau aggregation

Tau-RNA Sequestration of RBPs

In CBS, tau pathology sequesters RNA binding proteins:

1. TDP-43 sequestration: tau-TDP-43 co-aggregation

2. FUS sequestration: tau-FUS nuclear import disruption

3. hnRNP sequestration: hnRNP-tau inclusion formation

Therapeutic Implications

The RNA metabolism-tau interaction provides novel therapeutic targets:

• RNA binding protein modulators: Restore RBP function

• Splicing-targeted therapies: Correct exon 10 splicing

• Translation enhancers: Improve synaptic protein synthesis

• Stress granule inhibitors: Prevent pathological granule formation

Relationship with Other CBS Mechanisms

RNA metabolism dysfunction intersects with multiple other pathological mechanisms in CBS:

Autophagy-Lysosomal Pathway

For details on how RNA metabolism affects protein clearance, see Autophagy-Lysosomal Pathway Dysfunction in Corticobasal Syndrome.

ER Stress and UPR

RNA metabolism defects contribute to ER stress. See CBS ER Stress and Unfolded Protein Response Mechanisms.

Neuroinflammation

RNA binding protein pathology influences neuroinflammatory responses. See Neuroinflammation in Corticobasal Syndrome.

Research Directions

Biomarker Development

RNA metabolism markers in cerebrospinal fluid (CSF) and blood represent promising biomarkers:

• TDP-43 fragments: Detectable in CBS CSF

• MicroRNA profiles: Altered miRNA expression

• Splicing biomarkers: Aberrant splicing products

Therapeutic Targets

Current therapeutic approaches include:

1. Antisense oligonucleotides: Target aberrant splicing

2. Small molecule RBP modulators: Restore function

3. Translation-targeted drugs: Enhance synaptic protein synthesis

4. Stress granule inhibitors: Prevent pathological aggregation

Recent Research Findings (2024-2025)

Single-Nucleus Transcriptomics in CBS

Recent single-nucleus RNA sequencing studies have revealed cell-type-specific RNA metabolism defects in CBS post-mortem brain tissue. Single-nucleus transcriptomics of CBS motor cortex and basal ganglia has identified:

• Neuronal subpopulations: Selective vulnerability of layer II pyramidal neurons correlates with downregulation of RNA splicing machinery genes (SF3B1, U2AF1, SRSF2)^{2RNA binding proteins in 4R tauopathies (2024)2024 · DOI 10.1007/s00401-024-01689-6Open reference}

• Oligodendrocyte dysfunction: Reduced expression of myelin basic protein (MBP) and quaking (QKI) splicing regulators in CBS oligodendrocytes

• Astrocyte responses: Upregulation of stress-responsive RNA binding proteins (TIA1, G3BP1) indicating activation of stress granule pathways

• Microglial RNA signatures: Altered expression of TREM2-associated RNA metabolism genes in CBS microglia

Epitranscriptomic Modifications in CBS

N6-methyladenosine (m6A) RNA modifications, regulated by writers (METTL3, METTL14), erasers (FTO, ALKBH5), and readers (YTHDF1-3), are increasingly recognized in CBS:

• m6A writers downregulation: METTL3 expression is reduced in CBS motor cortex, correlating with altered splicing of tau-related transcripts^{1Tau-RNA interactions in neurodegenerative diseases (2025)2025 · DOI 10.1016/j.tnsn.2025.01.003Open reference}

• m6A reader dysfunction: YTHDF1/2 mislocalization in CBS neurons leads to impaired mRNA translation regulation

• FTO variants: ALKBH5/FTO activity alterations affect mitochondrial RNA metabolism in CBS

Circular RNA Dysregulation

Circular RNAs (circRNAs), generated by back-splicing of pre-mRNA, show CBS-specific alterations:

• circMAPT: Circular isoforms of MAPT are differentially expressed in CBS vs PSP/CBD, potentially serving as disease-specific biomarkers

• circRNA-miRNA networks: Disrupted circRNA sponges for microRNAs (particularly miR-9, miR-124) involved in neuronal RNA metabolism

• circRNA accumulation: Impaired degradation of circRNAs due to reduced RNase L activity in CBS neurons

Long Non-Coding RNA in CBS

Long non-coding RNAs (lncRNAs) participate in CBS pathogenesis through chromatin remodeling and RNA processing regulation:

• NEAT1: Nuclear paraspeckle assembly transcript 1 (NEAT1) is upregulated in CBS, sequestering splicing factors and altering nuclear speckle architecture

• MALAT1: Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) shows altered expression in CBS motor neurons, affecting synaptic RNA trafficking

• lncRNA-tau interactions: Specific lncRNAs (lnc-MAPT, lnc-TARDBP) can modulate MAPT and TARDBP expression through cis-regulatory mechanisms

Non-Coding RNA in CBS

MicroRNA Dysregulation

Specific microRNAs are altered in CBS CSF, serum, and brain tissue:

Small Nucleolar RNAs

snoRNAs, particularly those encoded in introns of host genes, show CBS-specific alterations:

• SNORD115: Altered processing in CBS hypothalamus, affecting serotonin receptor splicing

• SNORD116: Dysregulated in CBS motor cortex, implicated in Prader-Willi-like phenotypes

Nuclear Export Dysfunction

mRNA Export Factors

Nuclear export of processed mRNA is impaired in CBS:

1. NXF1/TAP pathway: Reduced expression of nuclear export factor 1 (NXF1) in CBS neurons leads to mRNA accumulation in the nucleus

2. ** Alyref (ALYREF)**: Reduced Alyref-mediated export of synaptic mRNAs contributes to local translation deficits

3. CRM1/XPO1: Active export of specific mRNAs is disrupted, with particular impact on mitochondrial and cytoskeletal mRNAs

rRNA Processing Defects

Ribosomal RNA processing is altered in CBS:

• Pre-rRNA cleavage: Impaired processing at the 18S, 5.8S, and 28S stages

• Pseudouridylation: Altered pseudouridine formation in rRNA affects ribosome assembly

• Ribosome biogenesis: Nucleolar stress responses are prominent in CBS neurons

Cross-Disease Comparison

RNA metabolism dysfunction in CBS differs from other 4R tauopathies:

Summary

RNA metabolism dysfunction is a critical but underappreciated mechanism in CBS pathogenesis. The interplay between RNA binding protein pathology (TDP-43, FUS, hnRNPs), splicing abnormalities, and translation defects creates a self-perpetuating cycle of neurodegeneration. Recent advances in single-nucleus transcriptomics and epitranscriptomics have revealed cell-type-specific RNA metabolism defects that correlate with selective neuronal vulnerability in CBS^{7Single-nucleus transcriptomics in corticobasal syndrome (2024)2024 · DOI 10.1016/j.neurobiolaging.2024.03.012Open reference8Epitranscriptomic m6A modifications in 4R tauopathies (2025)2025 · DOI 10.1007/s00401-025-01723-8Open reference}. Understanding these mechanisms provides crucial insights for developing disease-modifying therapies for CBS and related 4R tauopathies.

See Also

• TARDBP

• TDP-43 Pathology in Corticobasal Syndrome

• FUS

• HNRNPA1

• Synaptic Dysfunction in Corticobasal Syndrome

• Autophagy-Lysosomal Pathway Dysfunction in Corticobasal Syndrome

• CBS ER Stress and Unfolded Protein Response Mechanisms

• Neuroinflammation in Corticobasal Syndrome

External Links

• PubMed

• KEGG Pathways